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Abstract
Background: Peripheral changes to muscle and motor nerves occur following stroke, which may further impair
functional capacity. We investigated whether a year-long use of an implanted peroneal FES system reverses stroke-
related changes in muscles and motor nerves in people with foot drop in the chronic phase after supratentorial stroke.
Methods: Thirteen persons with a chronic stroke (mean age 56.1 years, median Fugl-Meyer Assessment leg score 71%)
were included and received an implanted peroneal FES system (ActiGait®). Quantitative muscle ultrasound (QMUS)
images were obtained bilaterally from three leg muscles (i.e. tibialis anterior, rectus femoris, gastrocnemius).
Echogenicity (muscle ultrasound gray value) and muscle thickness were assessed over a one-year follow-up and
compared to age-, sex-, height- and weight-corrected reference values. Compound motor action potentials (CMAPs)
and motor evoked potentials (MEPs) were obtained from the tibialis anterior muscle. Generalized estimated equation
modeling was used to assess changes in QMUS, CMAPs and MEPs outcomes over the follow-up period.
Results: Echogenicity of the tibialis anterior decreased significantly during the follow-up on the paretic side. Z-scores
changed from 0.88 at baseline to − 0.15 after 52 weeks. This was accompanied by a significant increase in muscle
thickness on the paretic side, where z-scores changed from − 0.32 at baseline to 0.48 after 52 weeks. Echogenicity of
the rectus femoris normalized on both the paretic and non-paretic side (z-scores changed from − 1.09 and − 1.51 to
0.14 and − 0.49, respectively). Amplitudes of CMAP and MEP (normalized to CMAP) were reduced during follow-up,
particularly on the paretic side (ΔCMAP = 20% and ΔMEP = 14%).
Conclusions: We show that the structural changes to muscles following stroke are reversible with FES and that these
changes might not be limited to electrically stimulated muscles. No evidence for improvement of the motor nerves
was found.
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Introduction
Stroke is typically defined as a lesion of the upper motor
neuron (UMN). However, it is known that secondary to
this UMN lesion peripheral changes occur after a stroke
[1, 2]. Following the loss of central activation, lower motor
neurons (LMN) may become functionally depressed or
may even undergo ‘transsynaptic degeneration’ leading to
denervation of muscle fibers [3–5]. Since denervation of
muscle fibers induces muscle atrophy and infiltration of
fibrous tissue and fat, this process of denervation after
stroke also has an effect on the structure of skeletal mus-
cles. Indeed, muscle atrophy and infiltration of fibrous
tissue and fat are often reported in paretic muscles after
stroke [6–8]. Recently we have shown that structural
changes to muscles after stroke are not restricted to the
paretic side alone and that the changes in muscle struc-
ture cannot be explained solely by disuse [9]. These
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changes to skeletal muscle structure are believed to fur-
ther impair functional capacity of people with stroke [8].
Therefore, interventions preventing or mitigating this un-
desirable involvement of the peripheral nerve system and
muscles after stroke are needed.
Functional electrical stimulation (FES) of paretic mus-
cles is a commonly applied method to compensate for
severe muscle weakness after stroke. One of the most
widely used applications of FES in people with stroke is
the activation of the peroneal nerve to reduce foot drop
[10]. With peroneal FES, paretic dorsiflexor muscles are
electrically activated during the swing phase and early
stance of the gait cycle, resulting in an ‘active’ foot eleva-
tion [11]. It has been theorized that such electrically
induced contractions combined with voluntary contrac-
tions can strengthen spinal synapses and induce cortical
changes [12]. Indeed, increased excitability, metabolism
and reorganization of the motor cortex have been re-
ported after prolonged peroneal FES use in people with
a neurological disease, including people with stroke [13–
16]. These plastic changes after long-term FES use indi-
cate central motor recovery, which raises the question
whether stroke-related changes to skeletal muscles and
lower motor neurons can also be reversed with pro-
longed FES use.
In this study we aimed to investigate whether a year-
long use of an implanted peroneal FES system (ActiGait®,
Neurodan, Denmark, Otto Bock Group, 2006) reverses
stroke-related changes in skeletal muscles and their
motor innervation in people with persistent foot drop
in the chronic phase after a supratentorial stroke. Bi-
lateral leg muscle thickness and echogenicity were
monitored over time using quantitative muscle ultra-
sound (QMUS), which is valid method for objective
assessment of muscle architecture [17–19] and has
been used in various patient populations with neuro-
muscular and central nervous system disorders [9, 20,
21]. Muscle thickness provides an indication of the
presence of muscle atrophy (or hypertrophy), whereas
echogenicity (i.e. how white or black the image looks
on the screen) is a measure of how (ab-) normal the
tissue architecture is. Infiltration of muscle fibers with
fat and fibrous tissue following denervation increases
muscle echogenicity, making the muscle appear more
white on the screen (see Fig. 1 for an example). Fur-
thermore, whether long-term FES stimulation of ankle
dorsiflexor muscles changes functioning of the lower
motor neurons and alters corticospinal integrity was
tested by obtaining compound motor action potentials
(CMAPs) and motor evoked potentials (MEPs) from
the primary ankle dorsiflexor muscle (i.e. tibialis an-
terior muscle).
We hypothesized that, following a year-long period of
implanted peroneal FES use, muscle architecture would
be restored in the electrically stimulated ankle dorsi-
flexor muscles, but not in other muscles on the paretic
or non-paretic side. In addition, as long-term use of FES
has been found to induce cortical changes, we hypothe-
sized that MEPs would be increased after a year of FES
use. The results of this study will lead to a better insight
into the reversibility of architectural changes of muscles
and motor nerves after stroke using long-term FES.
Methods
Participants
All participants were recruited from the outpatient clinic
of the department of Rehabilitation at the Radboud uni-
versity medical center in Nijmegen and were enrolled in
a study evaluating the effects of implanted functional
electrical stimulation (FES) on ambulation [22]. Inclu-
sion criteria were: (1) having sustained a supratentorial
stroke, i.e. a lesion in one of the cerebral hemispheres, at
least 6 months before inclusion, (2) paresis including
unilateral foot dorsiflexion weakness (Medical Research
Council scale < 5), (3) the ability to walk at least 10 m
without a walking aid (except for the use of an ankle-
foot orthosis which was allowed) and [4] a positive
response to surface-based peroneal nerve stimulation
(NESS L300, Bioness inc, Valencia, California) defined as
the ability to make initial heel contact during gait with
stimulation. Subjects were excluded if: (1) they had a
history of (poly-) neuropathy or (poly-) radiculopathy, or
(2) were morbidly obese (body mass index > 40), as this
can preclude reliable QMUS measurements by attenu-
ation of the ultrasound beam, or (3) reported contraindi-
cations for transcranial magnetic stimulation (TMS) (e.g.
active epilepsy or the presence of an implanted pace-
maker, neurostimulator or cochlear implant). All pa-
tients gave their informed consent. The study was
approved by the local medical ethics committee and
conducted in accordance with the World Medical Asso-
ciation Declaration of Helsinki [23].
Demographic and clinical characteristics
Age, sex, time since stroke, type of stroke, body mass
index, leg motor strength (Motricity Index [24]) and
leg motor selectivity (Fugl-Meyer Assessment [25])
were obtained by the same rehabilitation physician
(ACG) at inclusion. In addition, preferred walking
speed [26] at baseline and after 52 weeks of implanted
FES use was assessed on a 10-m walkway using a stop-
watch. Physical activity at baseline and after 52 weeks
of FES use was registered by means of a Digi-Walker
SW-650 pedometer (Yamax Corporation, Tokyo, Japan)
counting the amount of daily steps averaged over a
period of 7 days.
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ActiGait® implanted FES system
The ActiGait® system is an implantable 4-channel
peroneal nerve stimulator (Fig. 2). The implant consists
of an electrode cuff at the distal end and a stimulator
body at the proximal end connected by a lead wire. The
electrode cuff has 4 separate electrodes, which are
selectively controlled by the stimulator body, allowing
differential activation of nerve fibers to the tibialis anter-
ior, peroneus longus/brevis, and toe extensor muscles.
The system is operated through external parts: a heel
switch (placed under the heel and attached to the shoe
or a special sock) and a control unit, worn at the pelvis,
which is connected to an antenna on the skin directly
over the stimulator body. The control unit enables users
to switch the stimulation on and off and to make adjust-
ments in stimulation intensity. The heel switch wire-
lessly communicates with the control unit to provide
information for onset and offset of stimulation.
ActiGait® implantation was performed by a trained
neurosurgeon at the Radboud university medical center in
Nijmegen. The implant was activated 3 weeks after surgery.
Use of the Acitgait® system was then built up gradually in
3 weeks from 15 to 60min per day in the first week up to
minimally 6 h per day in the third week. The procedure of
ActiGait® implantation and system activation has previ-
ously been described in detail [27–29] and can be found in
the Additional file 1 of this report.
Study design
A within-subjects repeated-measures design was used
for the follow-up of 1 year after implantation. QMUS
measurements were performed at inclusion (T0) as well
as 26 weeks (T3) and 52 weeks (T4) after activation of
the ActiGait® system. Neurophysiologic assessments
were performed at inclusion (T0) and 2 weeks (T1), 8
weeks (T2), 26 weeks (T3) and 52 weeks (T4) after acti-
vation of the ActiGait® system. The effects of long-term
implanted FES use on walking capacity have been pub-
lished elsewhere [22, 29].
Measurements
Quantitative muscle ultrasound
We used QMUS, a method with high interrater reliability
[30–32], to assess the primary ankle dorsiflexor muscle
(i.e., the tibialis anterior muscle), its antagonist (i.e., the
medial head of the gastrocnemius muscle) and the rectus
femoris muscle, a biarticular upper leg muscle, all being
key muscles for locomotion. Muscle ultrasound images of
the tibialis anterior, medial head of the gastrocnemius,
and rectus femoris muscles were obtained bilaterally with
a Philips IU 22 ultrasound machine (Philips Healthcare
Systems, Best, The Netherlands) and a broadband linear
5–17MHz transducer. A dedicated musculoskeletal preset
was used for all scanning, with fixed system parameters
set to: gain 70 dB, compression 55, time gain in neutral
position, and focal range of 1.0 to 2.5 cm depth. To ensure
reproducibility, automatic image optimizing software was
turned off as much as possible. System settings remained
unchanged throughout all measurements [33]. Muscle
ultrasound images were taken at predefined sites corre-
sponding to the maximum muscle thickness of each
muscle, following the description of Scholten et al. [34].
At each assessment, three separate muscle ultrasound im-
ages were taken from each muscle, all the while ensuring
there was no pressure on the skin or the muscle and with
the participant in a relaxed, supine position. The digital
images were stored as DICOM files for offline analysis. In
each image a region of interest (ROI) was selected. Using
Fig. 1 Example of paretic side (a) and non-paretic side (b) tibialis anterior. The paretic tibialis anterior muscle appears whiter on the screen (i.e. a
higher echogenicity), indicating infiltration of intramuscular fat and fibrous tissue. Echogenicity z-scores were z = 1.45 and z = 0.29 for the paretic
and non-paretic side, respectively
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an image histogram analysis tool, the mean gray value and
thickness over the ROIs of separate muscles were calcu-
lated with the help of a custom software program
(“QUMIA”, [9, 19, 35–37]). This software then compared
the muscle thickness and gray values to age-, sex-, height-
and weight-corrected reference values [38, 39]. The differ-
ence found was expressed as a z-score, i.e. the number of
standard deviations (SD) from the mean. Positive z-scores
for echogenicity (i.e. muscles looking relatively white on
the screen) were considered indicative of poorer muscle
architecture with more infiltration of fibrous tissue and
fat. Negative z-scores for muscle thickness indicated loss
of muscle mass.
Electrophysiologic assessments
Surface EMG signals were recorded from the tibialis
anterior muscle on both the paretic and non-paretic
side. Adhesive electrodes (1 cm diameter) were placed
on the muscle belly and muscle tendon of the tibialis an-
terior muscle. Ground electrodes were placed between
the stimulus and recording site. EMG recordings were
performed using a multichannel biomedical amplifier
(Neurotop MME 3132, Nihon Kohden, Tokyo, Japan).
Peripheral motor nerve stimulation
Peripheral motor nerve function was evaluated by
measuring the CMAPs from the tibialis anterior
muscle. Assessment of CMAPs from the tibialis anter-
ior muscle has been shown to have good test-retest
reliability [40]. CMAPs were obtained, for the paretic
and non-paretic side separately, by stimulation of the
common peroneal nerve, dorsal to the fibular head.
Stimulation intensity was increased gradually until an
increase in intensity did not further increase the motor-
wave (M-wave) amplitude (i.e. supramaximal stimula-
tion). The results of five consecutive stimulations were
then recorded and used for analysis. After rectification
of the raw signal, the maximum peak-to-peak ampli-
tude and the largest area under the curve (AUC) of
these five contractions were extracted offline, using a
custom Matlab script (Matlab 20141b, The Mathworks
Inc. Natick, Massachusetts).
Transcranial magnetic stimulation
For assessment of the corticospinal connections to the
tibialis anterior, MEPs were obtained using TMS. The
motor cortex was stimulated three times at the vertex
with a double-cone coil at maximal stimulator output
using a transcranial magnetic stimulator (Magstim 200,
Magstim, Whitland, UK). The MEPs were recorded
when participants performed a slight voluntary ankle
dorsiflexion to enlarge the MEP response. From the
three stimuli obtained in each assessment, participants’
maximum peak-to-peak amplitude as well as the largest
AUC after rectification of the raw signal were extracted
offline using a custom Matlab script (Matlab 2041b, The
Mathworks Inc. Natick, Massachusetts). Since MEP out-
put is limited by functioning of the lower motor neuron,
MEP peak-to-peak amplitude and AUC were also nor-
malized to CMAP amplitude and AUC, for instance:
(MEPamplitude/CMAPamplitude)*100%.
Statistical analysis
To test whether group means of echogenicity and
muscle thickness at baseline were different from normal
Fig. 2 The ActiGait® system. The implanted part of the ActiGait®
consists of a stimulator body (a) and an electrode cuff (b), the latter
placed around the common peroneal nerve. The implant is controlled
by a control unit (c), which activates the implant through an antenna
placed on the thigh (d). The timing of activation is determined by a
heel switch (e), which communicates wirelessly with the control unit
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values, a one sample t-test (test value: μ = 0) was per-
formed. Baseline differences in echogenicity and muscle
thickness between the paretic and non-paretic side were
tested using paired samples t-tests. Generalized esti-
mated equation modeling (GEE), with time (T0-T4) and
side (paretic and non-paretic) as the independent vari-
ables, was used to assess changes over the follow-up
period in the dependent variables: muscle echogenicity,
muscle thickness, CMAP amplitude and AUC and
(normalized) MEP amplitude and AUC. Since we ex-
pected that assessments obtained shortly after each
other (e.g. T1 and T2) would be correlated stronger than
assessments with a longer time interval (e.g. T2 and T3),
we selected an autoregressive structure as the working
correlation structure of the GEE model. In the case of a
significant interaction of side by time, additional GEE
analyses of time effects were performed for the paretic
and non-paretic side, separately. These additional ana-
lyses of time per body side were corrected for multiple
comparisons using Bonferroni correction. To assess
changes in walking activity and capacity (steps per day
and comfortable walking speed) Wilcoxon signed-rank
tests were performed. We used SPSS (SPSS 15.0, SPSS
Inc., Chicago, Illinois) for all statistical analyses. The
level of significance was set at p < 0.05.
Results
The characteristics of the included participants are pre-
sented in Table 1. One participant died before the first
follow-up measurement, the cause of death being unre-
lated to the study; data of this participant was removed
from the analysis. In one participant the FES system
failed after 26 weeks. Since sufficient follow-up data were
obtained, this participant was included in the final ana-
lysis. Hence, data of a total of 12 participants were used
for final analysis. After 1 year of FES use the number of
steps per day (6248 ± 3019, p = 0.59) and comfortable
walking speed (1.02 ± 0.2 m/s, p = 0.09) were not signifi-
cantly different from baseline values (5794 ± 2671 and
0.97 ± 0.2, respectively).
Quantitative muscle ultrasound
Tibialis anterior
At baseline, the mean echogenicity of the tibialis anterior
muscle was significantly higher on both the paretic and
non-paretic side (z = 0.88, p = 0.001, and z = 0.65, p = 0.008,
respectively), meaning that the muscles looked more white
and hence more structurally abnormal on the screen com-
pared to reference values. Baseline echogenicity was not
found to be significantly different between the paretic and
non-paretic side. Over the follow-up period we found a
decrease in tibialis anterior echogenicity which was most
profound on the paretic side, as reflected by a significant
interaction effect of time by side (p < 0.001). Echogenicity
z-scores on the paretic side were significantly different from
baseline at T3 (p < 0.001) and T4 (p < 0.001) and decreased
on average by 1.03 SD, indicating that muscle architecture
improved over time. Remarkably, the echogenicity of
the paretic side became lower than that of the non-
paretic side at T4 (see Fig. 3a). We also found a signifi-
cantly decreased echogenicity on the non-paretic side
at T4 compared to T0, however, this finding was driven
by imputation of two missing values at T4 by the GEE
model. Additional parametric t-tests did not reveal a
significant difference in echogenicity between baseline
and T4 on the non-paretic side (p = 0.180).
At baseline, no significant differences compared to ref-
erence values or between the paretic and non-paretic
side were found for muscle thickness of the tibialis an-
terior. Muscle thickness of the tibialis anterior on the
paretic side increased over the follow-up period, being
significantly different from baseline at T3 (p < 0.001)
and T4 (p = 0.001; average increase of 0.80 SD, see Fig.
3b), whereas the muscle thickness on the non-paretic
side did not (interaction time by side, p < 0.001).
Medial head of gastrocnemius
At baseline, the mean echogenicity of the medial head of
the gastrocnemius muscle was significantly higher on
the paretic side compared to reference values (p = 0.019)
and compared to the non-paretic side (p = 0.007). The
mean echogenicity did not change over time for either
the paretic or non-paretic side. Overall, mean z-scores
for echogenicity of the paretic and non-paretic side were
1.59 and − 0.13, respectively (see Fig. 3c).
Similar to the echogenicity pattern of the gastrocne-
mius, the paretic side muscle thickness at baseline was
significantly smaller than reference values (p = 0.002)
and compared to the non-paretic side (p = 0.006). Over
the follow-up period muscle thickness remained signifi-
cantly different between the paretic and non-paretic side
Table 1 Baseline group characteristics
N 13
Age; mean yrs. (SD) 56.1 (10.2)
Sex; male/female 10/3
Affected side; left/right 8/5
Type of stroke; ischaemic/ haemorrhagic 9/4
Years after stroke; mean yrs. (SD) 5.2 (4.5)
Body Mass Index; mean kg/m2(SD) 26.7 (3.4)
Fugl-Meyer Assessment – leg score
(0–100%); median score (range)
71 (53–85)
Motricity Index – leg score (0–100%);
median score (range)
72 (42–91)
Walking speed; mean m/s (SD) 0.97 (0.2)
Step count; mean steps/day (SD) 5794 (2671)
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(mean muscle thickness z-scores − 2.56 and − 0.81, re-
spectively, p < 0.001), indicating that both sides showed
reduced muscle thickness at a group level. Similar to the
echogenicity, no significant changes in muscle thickness
were found over time during FES use (see Fig. 3d).
Rectus femoris
At baseline, the mean echogenicity of the rectus femoris
muscle was significantly lower than reference values on
both the paretic side and non-paretic side (z = − 1.09,
p = 0.014, and z = − 1.51, p = 0.002, respectively). Base-
line echogenicity was not significantly different between
the paretic and non-paretic side. During the follow-up
period we found a significant change in echogenicity for
both the paretic and non-paretic side at 52 weeks (T4)
compared to T0 (p = 0.021). On average, echogenicity z-
scores increased by 1.24 and 1.01 for the paretic and
non-paretic side, respectively. Thus, after 1 year of FES
use, mean echogenicity values for both the paretic and
non-paretic side returned within one SD of the reference
values (see Fig. 3e).
At baseline, mean rectus femoris muscle thickness on
the paretic and non-paretic side were not significantly
different from reference values. Paretic side muscle
thickness was significantly smaller compared to the non-
paretic side (p = 0.009), which was maintained over the
follow-up period (p = 0.001). On average, paretic and
non-paretic z-scores were − 0.58 and 0.08, respectively,
indicating that only the paretic side showed reduced
muscle thickness. No significant changes in rectus
femoris thickness on either side could be detected over
time (see Fig. 3f ).
Electrophysiologic assessment
Compound motor action potentials
The CMAP AUC and amplitudes of the tibialis anterior
muscle were generally lower on the paretic side com-
pared to the non-paretic side (p < 0.001). Following FES
implantation, differences in CMAP AUC between the
paretic and non-paretic side became larger (interaction
time by side p < 0.002). This significant interaction of
time by side was driven by a significant reduction in
CMAP AUC on the paretic side (see Fig. 4a). It
decreased from 58.7mVms (T0) to 46.0mVms (T4), and
was found to be significantly different from baseline
values during the entire follow-up period (p < 0.004).
Similarly, an interaction of time by side was found for
CMAP amplitudes (p < 0.005). Again, this interaction
was driven by significant changes on the paretic side
(see Fig. 4b). CMAP amplitudes on the paretic side de-
creased from 8.0 mV (T0) to 6.4 mV (T2, p < 0.001).
Fig. 3 a-f Mean estimated z-scores ± standard errors for echogenicity and muscle thickness of the tibialis anterior (a, d), medial gastrocnemius (b,
e), and rectus femoris (c, f) muscles over time: paretic side (circles, solid lines) and non-paretic side (triangles, dashed lines). Positive z-scores for
echogenicity are considered indicative of poor muscle quality, whereas negative z-scores for muscle thickness indicate muscle atrophy. Grey
bands represent the area within 1.0 SD of the reference values.Tables with estimated means and standard errors can be found in Additional file 2
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Subsequent analysis of the CMAP AUC and ampli-
tudes showed no further changes from T1 or T2 to T4,
indicating that the bilateral loss of CMAP amplitude/
AUC after the surgical intervention was not fully re-
versed during the 1-year follow-up period.
Motor evoked potentials
MEP AUC and amplitudes of the tibialis anterior muscle
were generally lower on the paretic side compared to the
non-paretic side (p < 0.036). Similar to the CMAP AUC
and amplitudes, the differences in MEP AUC between the
paretic and non-paretic side became larger during the
follow-up period, as was reflected by a significant inter-
action of time by side (p = 0.005). Also for MEP AUC, this
significant interaction of time by side was due to a de-
crease on the paretic side, which was significantly different
from baseline at T2 (p < 0.001). Between baseline and T2,
mean MEP AUC decreased from 47.9mVms to 33.1mVms
on the paretic side (see Fig. 4c).
MEP amplitudes on the paretic and non-paretic side
decreased from 4.2 to 3.1 mV and from 6.6 to 6.0 mV,
respectively. Although the average decrease in MEP am-
plitudes on the paretic side was nearly twofold the
change on the non-paretic side,
no significant interaction of time by side was found (p =
0.119 at T2, see Fig. 4d). In general, MEP amplitudes were
significantly different from baseline during the entire
follow-up, T1-T4 (p < 0.046).
To assess whether changes over time in MEPs were
due to changes in CMAPs we tested the effects of time
and side on normalized MEPs. In contrast to MEP AUC,
no significant interaction of time by side was found.
Overall, normalized MEP AUC was significantly reduced,
only at T2 (p < 0.001). With normalization of MEP am-
plitudes part of the time effects for MEP amplitudes,
reported above, disappeared. With normalized MEP am-
plitudes significant differences in time were found only
at T2 (p < 0.001) and T4 (p = 0.038).
Discussion
Our study confirms that structural changes in skeletal
muscle after a supratentorial stroke, reported here and
elsewhere [9, 41–45], appear to be reversible with long-
term FES use. Echogenicity of the tibialis anterior muscle
decreased during the follow-up on the paretic side, which
was accompanied by an increase in muscle size. Because of
the chronic condition of the participants, it is unlikely that
these changes are attributable to spontaneous recovery.
Quantitative muscle ultrasound
In agreement with our hypothesis, the year-long use of an
implanted peroneal FES stimulator successfully reversed
the maladaptive changes to muscle structure in the tibialis
Fig. 4 a-d Mean estimated area under the curve and peak-to-peak amplitudes ± standard errors for compound motor action potentials (a, b) and motor
evoked potentials (c, d) obtained from tibialis anterior muscle over time: paretic side (circles, solid lines) and non-paretic side (triangles, dashed lines). Tables
with estimated means and standard errors can be found in Additional file 2
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anterior muscle. Previous studies have shown that FES
can be successful in stopping or counteracting muscle at-
rophy, but this was done in other groups of patients (e.g.,
spinal cord injury) and through a resistance training pro-
gram specifically aimed at muscle mass gain using
surface-based FES stimulation [46–48]. The reduction in
echogenicity on the paretic side of 1.03 SD comes down
to a change in absolute echogenicity of approximately 20%
[38], which is well over the 10% variation that could be ex-
pected between measurements [31]. Reduced echogenicity
in the tibialis anterior muscle may have (partly) been
caused by an increase in muscle mass [49], something we
observed on the paretic side. However, the changes in
echogenicity on the paretic side exceeded the changes in
muscle thickness, which makes it unlikely that the ob-
served decrease in echogenicity would be merely due to
activity-induced muscle hypertrophy.
Since the implanted FES stimulator acts on the ankle
dorsiflexor muscles, we hypothesized that no significant
changes would occur in the medial gastrocnemius or rec-
tus femoris muscle during 1 year of FES use. Although
this was true for the medial head of the gastrocnemius, we
did find changes in rectus femoris echogenicity during the
follow-up period. Unexpectedly, and unlike the other
muscles, the average echogenicity of the rectus femoris
muscle was bilaterally lower than the reference values at
baseline. This finding contrasts with the recent work by
Akazawa et al. who reported increased echogenicity in the
paretic rectus femoris muscles of sedentary and active
people with stroke [45]. However, in the study by Akazawa
et al., echogenicity was not corrected for age, sex, height
or weight, as we did in the current study. As a result, dir-
ect comparison of the two studies is not possible. We have
no explanation for the relatively low echogenicity of both
rectus femoris muscles as observed in our study, however,
our results indicate that this echogenicity was normalized
after one-year of FES use. The normalization of echogeni-
city might point at a changed activity of the rectus femoris
muscles as a result of FES use, at least on the paretic side,
but this post-hoc explanation needs further investigation.
Neurophysiologic assessment
Our results indicate that the CMAPs from the tibialis
anterior muscle of the stimulated leg decreased after im-
plantation of the FES system, a finding which we did not
expect. The marked decline of the CMAP amplitudes on
the paretic side (i.e. a loss of about 20%) could theoretic-
ally result from a reduction of functionally active motor
units (e.g. due to nerve damage upon implantation) or
from a lower excitability of motor unit components (i.e.
axons, neuromuscular junctions and/or muscle fibers).
Given the invasive character of the intervention, it is
possible that the common peroneal nerve might have
been damaged during surgery. However, if this would
have been the case, we would have expected problems
stimulating the tibialis anterior muscles and we would
have expected signs of denervation of this muscle (i.e.,
increase in echogenicity and decrease in muscle size),
which we did not find. We therefore believe that it is
most likely that the excitability of the common peroneal
nerve changed following implantation and, particularly,
following activation of the FES stimulator. Indeed,
axonal excitability can change under various conditions
including overuse and fatigue [50, 51], and rapidly
fatiguing muscles are a well-known problem in the ap-
plication of FES [52]. Although participants were
instructed to build up their daily FES use slowly and
gradually, it might be that the paretic neuromuscular
complex needed more time or was unable to adjust to
the suddenly increased activation. Signs of fatigue were
commonly reported by the participants, especially during
the first weeks of follow-up. Additionally, it might be
that the nature of FES provides a very different stimula-
tion context for the motor axons than physiologic
activation does, with concomitant changes in axonal
resting and firing thresholds that may lead to a decrease
in single-stimulus CMAP parameters.
In a number of studies, the use of FES has been shown
to induce plastic changes on a cortical level [13–16]. Like
in our study, Everaert et al. used MEPs to assess the effects
of FES on cortical plasticity. In contrast to their work, we
did not find signs of cortical plasticity after a year-long
FES use. Instead, in our study, MEP amplitudes from the
tibialis anterior muscle were even slightly reduced during
the follow-up period. However, direct comparison of the
results derived from both studies should be done with
caution, given an important difference in measurement
protocol. Where we used a fixed position of the magnetic
stimulator for eliciting MEPs throughout the follow-up
period, Everaert et al. aimed for the localization of ‘hot
spots’ to achieve the best MEP response.
Study limitations and recommendations
We assessed changes in three muscles in a relatively
small and specific group of chronic stroke patients. The
participants in our sample showed reduced ambulatory
capacity, but were relatively active compared to the
stroke community at large. The group in our study
walked on average about 5800 steps per day, which is
well above the number of steps reported in other studies
[53]. To assure reliable imaging of muscles with muscle
ultrasound, stroke survivors who were morbidly obese
were excluded from the study. Since people with stroke
are often obese and inactive, our results may therefore
not be representative for the entire group of stroke sur-
vivors. However, our data show that even in active
people with stroke structural changes in muscle archi-
tecture can be reversed, in our case by applying peroneal
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FES. Although we compared muscle characteristics to
height-, weight-, sex- and age-corrected reference values,
it is still uncertain whether the changes obtained in our
study are clinically relevant. Future studies should aim at
identifying cut-off criteria for relevant changes in both
echogenicity and muscle thickness in this study popula-
tion. In addition, other factors might influence muscle
ultrasound characteristics in people with stroke, such as
their hydration status that can change with the use of di-
uretics. The effects of such variables should be investi-
gated in future research. Finally, this study focused on
reversing the structural changes to muscle and nerves in
people with chronic stroke (> 6 months post onset). It
might be interesting to investigate whether FES could
also be used to prevent such structural changes in the
first months after a stroke.
Conclusion
We have shown that the structural changes to muscles
following supratentorial stroke are reversible with im-
planted peroneal FES and that these findings are not re-
stricted to the stimulated ankle dorsiflexor muscles
alone. We could not identify improvement of lower
motor neuron functioning or cortical plasticity. The
findings in this study add to the evidence that peroneal
FES may have added value over the use of an ankle-foot
orthosis in people with unilateral drop foot after stroke.
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